ACC 2014 schedule: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(59 intermediate revisions by the same user not shown)
Line 19: Line 19:


==Saturday, March 29, 2014==
==Saturday, March 29, 2014==
===8:00 AM===
<font color=red>OPEN TIME SLOT</font>
===8:30 AM===
<font color=red>OPEN TIME SLOT</font>
===9:00 AM===
<font color=red>OPEN TIME SLOT</font>
===9:30 AM===
<font color=red>OPEN TIME SLOT</font>


===10:00 AM===
===10:00 AM===
<font color=red>OPEN TIME SLOT</font>
''10:00AM - 10:30AM''
*'''Interviewee:''' Dr. P.J. Devereaux
*'''Topic:''' The Impact of Acetyl-Salicylic Acid on Major Arterial and Venous Complications in Patients Undergoing Noncardiac Surgery
*'''Embargo Lift:''' Monday, March 31, 2014 at 8:00am


===10:30 AM===
===10:30 AM===
<font color=red>OPEN TIME SLOT</font>
''10:30 AM - 11:00AM''
*'''Interview:''' Dr. Nadia Bandstein
*'''Topic:''' Negative High-Sensitive Troponins in the Emergency Department and Risk of Myocardial Infarction
*'''Embargo lift:''' Sunday, March 30, 2014 at 11:45am


===11:00 AM===
===2:00 PM===
<font color=red>OPEN TIME SLOT</font>
<font color=red>OPEN TIME SLOT</font>
===2:00 PM===
''2:00 PM - 2:30 PM''
*'''Interview:'''Dr. Ilan Goldenberg
*'''Topic:'''  Long-term Survival with Cardiac Resynchronization Therapy in Patients with Mild Heart Failure
*'''Embargo lift:''' Sunday, March 30, 2014 at 11:30 AM


===2:30 PM===
===2:30 PM===
Line 51: Line 39:
*'''Interviewee:'''Dr. Jennifer Robinson
*'''Interviewee:'''Dr. Jennifer Robinson
*'''Topic:''' The Low-density Lipoprotein Cholesterol Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy - 2 Trial: A Phase 3, Double-blind, Randomized, Placebo and Ezetimibe Controlled, Multicenter Study to Evaluate Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Combination With Statin Therapy in Subjects With Primary Hypercholesterolemia and Mixed Dyslipidemia
*'''Topic:''' The Low-density Lipoprotein Cholesterol Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy - 2 Trial: A Phase 3, Double-blind, Randomized, Placebo and Ezetimibe Controlled, Multicenter Study to Evaluate Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Combination With Statin Therapy in Subjects With Primary Hypercholesterolemia and Mixed Dyslipidemia
*'''Embargo Lift:''' Sunday, March 30, 2014 at 8:15am   Normal  0          false  false  false    EN-US  X-NONE  X-NONE                                                                                                                                                                                                                                                                                                                                                           
*'''Embargo Lift:''' Sunday, March 30, 2014 at 8:15am


===3:00 PM===
===3:00 PM===
Line 64: Line 52:
*'''Topic:''' Evaluation of the Dual PPAR-α/γ Agonist Aleglitazar to Reduce Cardiovascular Events in Patients with Acute Coronary Syndrome and Type 2 Diabetes Mellitus: the AleCardio Trial  
*'''Topic:''' Evaluation of the Dual PPAR-α/γ Agonist Aleglitazar to Reduce Cardiovascular Events in Patients with Acute Coronary Syndrome and Type 2 Diabetes Mellitus: the AleCardio Trial  
*'''Embargo lift:''' Monday, March 31, 2014 at 11:30 AM
*'''Embargo lift:''' Monday, March 31, 2014 at 11:30 AM
===4:00 PM===
''4:00 PM - 4:15 PM''
*'''Interviewee:''' Dr. Ajay Kirtane
*'''Topic:''' Daily ACC Wrap-up in English


== Sunday, March 30, 2014==
== Sunday, March 30, 2014==
===9:00 AM===
''9:00 AM - 9:30AM''
'''*TCTMD Studio Not Available'''
===9:30 AM===
''9:30 AM - 10:30AM''
'''*TCTMD Studio Not Available'''
===10:00 AM===
''10:00 AM - 10:30AM''
'''*TCTMD Studio Not Available'''
===10:30 AM===
''10:30 AM - 11:30AM''
'''*TCTMD Studio Not Available'''
===11:00 AM===
<font color=red>OPEN TIME SLOT</font>
===11:30 AM===
<font color=red>OPEN TIME SLOT</font>
===12:00 PM===
''12:00 PM - 12:30 PM''
<font color=red>OPEN TIME SLOT</font>
===12:30 PM===
''12:30 PM - 1:00 PM''
*'''Interviewee:''' Dr. Masahiro Natsuaki
*'''Topic:''' Two-year Outcome of a Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer: the NOBORITM Biolimus-Eluting versus XIENCETM/PROMUSTM Everolimus-eluting Stent Trial (NEXT)
*'''Embargo Lift:''' Sunday, March 30, 2014 at 8:45am


===1:00 PM===
===1:00 PM===
''1:00 PM - 1:30 PM''
*'''Interview:''' Dr. Anders Bruun Mathiasen and Professor Jens Kastrup
*'''Interview:''' Dr. Anders Bruun Mathiasen and Professor Jens Kastrup
*'''Topic:''' Autotransplantation of Bone Marrow Derived Mesenchymal Stromal Cells in Patients with Severe Ischemic Heart Failure: The MSC-HF Trial
*'''Topic:''' Autotransplantation of Bone Marrow Derived Mesenchymal Stromal Cells in Patients with Severe Ischemic Heart Failure: The MSC-HF Trial
Line 73: Line 99:


===1:30 PM===
===1:30 PM===
<font color=red>OPEN TIME SLOT</font>
''1:30 PM - 2:00 PM''
*'''Interviewee:''' Dr. Rogerio Sarmentio-Leite
*'''Topic:''' ACC Wrap-up in Portuguese


===2:00 PM===
===2:00 PM===
''2:00 PM - 2:30 PM''
''2:00PM - 2:30 PM''
*'''Interviewee:''' Dr. Aimee Armstrong
*'''Interviewee:''' Dr. Basil Lewis
*'''Topic:''' One Year Follow-up of the Melody Transcatheter Pulmonary Valve Multicenter Post Approval Study
*'''Topic:''' ACC Wrap-up in Hebrew
*'''Embargo Lift:''' Sunday, March 30, 2014 at 11:15am


===2:30 PM===
===2:30 PM===
<font color=red>OPEN TIME SLOT</font>
''2:30 PM - 3:00 PM''
*'''Interview:'''Dr. Ilan Goldenberg
*'''Topic:''' Long-term Survival with Cardiac Resynchronization Therapy in Patients with Mild Heart Failure
*'''Embargo lift:''' Sunday, March 30, 2014 at 11:45 AM


===3:00 PM===
===3:00 PM===
<font color=red>OPEN TIME SLOT</font>
<font color=red>OPEN TIME SLOT</font>
===3:30 PM===
''3:30 PM - 4:00 PM''
*'''Interviewee:''' Dr. Roxana Mehran
*'''Topic:''' ACC Wrap-up in English
===4:00 PM===
''4:00 PM - 4:30 PM''
*'''Interviewee:''' Dr. Ajay Kirtane
*'''Topic:''' ACC Wrap-up in English
===4:30 PM===
''4:30 PM - 5:00PM''
'''*TCTMD Studio Not Available'''
===5:00PM===
''5:00 PM - 5:30 PM''
'''*TCTMD Studio Not Available'''
===5:30PM===
''5:30PM - 6:00 PM''
'''*TCTMD Studio Not Available'''
===6:00PM===
''6:00 PM - 6:30 PM''
'''*TCTMD Studio Not Available'''


==Monday, March 31, 2014==
==Monday, March 31, 2014==


===8:00 AM===
===8:00 AM===
<font color=red>OPEN TIME SLOT</font>
''8:00AM - 8:30AM''
*'''Interviewee:''' Dr. Deepak Bhatt
*'''Topic:''' The Main Results of SYMPLICITY HTN-3
*'''Embargo Lift:''' Saturday, March 29, 2014 at 9:35am


===8:30 AM===
===8:30 AM===
<font color=red>OPEN TIME SLOT</font>
''8:30AM - 9:00AM''
*'''Interviewee:''' Dr. Stefan James
*'''Topic:''' ACC Wrap-up from the Scandinavian Perspective


===9:00 AM===
===9:00 AM===
<font color=red>OPEN TIME SLOT</font>
''9:00 AM - 9:30 AM''
*'''Interviewee:''' Dr. David Adams
*'''Topic:''' A Randomized Comparison of Self-expanding Transcatheter and Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis Deemed High-Risk for Surgery
*'''Embargo Lift:''' Saturday, March 29, 2014 at 9:10am


===9:30 AM===
===9:30 AM===
Line 102: Line 166:


===10:00 AM===
===10:00 AM===
<font color=red>OPEN TIME SLOT</font>
''10:00 AM - 10:30 AM''
*'''Interviewee:''' Dr. Massimo Imazio
*'''Topic:''' Efficacy And Safety Of Colchicine In Patients With Multiple Recurrences Of Pericarditis: Results Of A Multicenter, Double-blind, Placebo-controlled, Randomized Study (corp-2 Trial)
*'''Embargo Lift:''' Sunday, March 30, 2014 at 10:45am


===10:30 AM===
===10:30 AM===
<font color=red>OPEN TIME SLOT</font>
''10:30 AM - 11:00AM''
*'''Interviewee:''' Dr. Aimee Armstrong
*'''Topic:''' One Year Follow-up of the Melody Transcatheter Pulmonary Valve Multicenter Post Approval Study
*'''Embargo Lift:''' Sunday, March 30, 2014 at 11:15am


===11:00 AM===
===11:00 AM===
<font color=red>OPEN TIME SLOT</font>
''11:00AM - 11:30AM''
*'''Interviewee:''' Dr. Phillip Raymond Schauer
*'''Topic:''' Effect of Bariatric Surgery vs. Intensive Medical Therapy on Long-term Glycemic Control and Complications of Diabetes: 3-Year STAMPEDE Trial Results
*'''Embargo Lift:''' Monday, March 31, 2014 at 9:00am


===11:30 AM===
===11:30 AM===
<font color=red>OPEN TIME SLOT</font>
''11:30AM - 12:00PM''
*'''Interviewee:''' Dr. Ajay Kirtane
*'''Topic:''' ACC Wrap-up in English


===12:00 PM===
===12:00 PM===
Line 119: Line 194:


===12:30 PM===
===12:30 PM===
<font color=red>OPEN TIME SLOT</font>
''12:30 PM - 1:00 PM'' '''*TCTMD Webcast - Studio Not Available'''
*'''Interviewee:''' Dr. Richard Whitlock
*'''Topic:''' Steroids in Cardiac Surgery (SIRS)
*'''Embargo Lift:''' Monday, March 31, 2014 at 8:30am


===1:00 PM===
===1:00 PM===
''1:00 PM - 1:30 PM''
''1:00 PM - 1:30 PM'' '''*TCTMD Webcast - Studio Not Available'''
*'''Interviewee:''' Dr. Gennaro Sardella
*'''Interviewee:''' Dr. Gennaro Sardella
*'''Topic:''' ACC Wrap-up in Italian
*'''Topic:''' ACC Wrap-up in Italian


===1:30 PM===
===1:30 PM===
''1:30 PM - 2:00 PM''
''1:30 PM - 2:00 PM'' '''*TCTMD Webcast - Studio Not Available'''
*'''Interviewee:''' Dr. Daniel Sessler
*'''Interviewee:''' Dr. Daniel Sessler
*'''Topic:''' A Large International Trial Assessing the Effects of Clonidine on Major Arterial Events in Patients Having Noncardiac Surgery
*'''Topic:''' A Large International Trial Assessing the Effects of Clonidine on Major Arterial Events in Patients Having Noncardiac Surgery
Line 133: Line 211:


===2:00 PM===
===2:00 PM===
''2:00 PM – 2:30 PM''
''2:00 PM – 2:30 PM''  '''*TCTMD Webcast -Studio Not Available'''
*'''Interviewee:''' Dr. Juan Gaspar
*'''Interviewee:''' Dr. Juan Gaspar
*'''Topic:''' ACC Wrap-Up in Spanish
*'''Topic:''' ACC Wrap-Up in Spanish
Line 144: Line 222:
===3:00 PM===
===3:00 PM===
''3:00 PM - 3:30 PM''
''3:00 PM - 3:30 PM''
*'''Interviewee:''' Dr. Roxana Mehran
*'''Interviewee:''' Dr. Mohamed Abdel-Wahab
*'''Topic:''' ACC Wrap Up in English
*'''Topic:'''A Randomized Comparison of Self-Expandable and Balloon-Expandable Prostheses in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement - The CHOICE Trial
*'''Embargo Lift:''' Sunday, March 30, 2014 at 8:00am


===3:30 PM===
===3:30 PM===
<font color=red>OPEN TIME SLOT</font>
''3:30 PM - 4:00 PM''
*'''Interviewee:''' Dr. Gilles Montalescot
*'''Topic:''' ACC Wrap-up in French


===4:00 PM===
===4:00 PM===
Line 154: Line 235:
*'''Interviewee:''' Dr. David Holmes
*'''Interviewee:''' Dr. David Holmes
*'''Topic:''' One Year Outcomes from the STS/ACC Transcatheter Valve Therapy (TVT) Registry
*'''Topic:''' One Year Outcomes from the STS/ACC Transcatheter Valve Therapy (TVT) Registry
*'''Embargo Lift:''' Monday, March 31, 2014 at 10:45am   Normal  0          false  false  false    EN-US  X-NONE  X-NONE                                                                                                                                                                                                                                                                                                                                                           
*'''Embargo Lift:''' Monday, March 31, 2014 at 10:45am


===4:30 PM===
===4:30 PM===
<font color=red>OPEN TIME SLOT</font>
''4:30PM - 5:00PM''
*'''Interviewee:''' Dr. Chris Lexis
*'''Topic:''' Metformin in Acute Myocardial Infarction
*'''Embargo Lift:''' Monday, March 31, 2014 at 8:45am
 
===5:00 PM===
''5:00 PM - 5:20 PM''
*'''Interviewee:''' Dr. Adeel Shahzad and Dr. Rod Stables (PI on Study)
*'''Topic:''' Unfractionated Heparin versus Bivalirudin in Primary Percutaneous Coronary Intervention: A Unique Randomized Controlled Trial with Consecutive, Unselected Patient Enrollment (using Delayed Consent), Designed to Reflect Real-World, Contemporary Practice
*'''Embargo Lift:''' Monday, March 31, 2014 at 12:30pm
 
===5:20 PM===
''5:20 PM - 5:40 PM''
*'''Interviewee:''' Professor Harvey White
*'''Topic:''' Effect of Inhibition of Lipoprotein-Associated Phospholipase A2 with Darapladib on Ischemic Events in Patients with Chronic Coronary Heart Disease: The STABILITY (STabilisation of Atherosclerotic plaque By Initiation of darapLadIb TherapY) Trial '''and''' ACC Wrap-up from the Pacific Rim Perspective
*'''Embargo Lift:''' Sunday, March 30, 2014 at 8:00am


==Tuesday, April 1, 2014==
==Tuesday, April 1, 2014==


===8:00 AM===
===8:00 AM===
''8:00 AM - 8:30 AM''
<font color=red>OPEN TIME SLOT</font>
*'''Interviewee:''' Dr. Paul Armstrong
*'''Topic:''' ACC Wrap Up from a Canadian Perspective


===8:30 AM===
===8:30 AM===
Line 170: Line 264:


===9:00 AM===
===9:00 AM===
''9:00 AM - 9:30 AM''
''9:00 AM - 9:30 AM'' *'''TCTMD Studio Not Available'''
*'''Interviewee:''' Dr. Sigmund Silber
*'''Interviewee:''' Dr. Sigmund Silber
*'''Topic:''' ACC Wrap Up in German
*'''Topic:''' ACC Wrap Up in German

Latest revision as of 17:00, 27 March 2014

Here is the page we will use to coordinate the TV events at ACC 2014. Open time slots are indicated below in red.

Filming location TBD.


Click on Date for Detailed Schedule

Saturday, March 29, 2014

Sunday, March 30, 2014

Monday, March 31, 2014

Tuesday, April 1, 2014

Saturday, March 29, 2014

10:00 AM

10:00AM - 10:30AM

  • Interviewee: Dr. P.J. Devereaux
  • Topic: The Impact of Acetyl-Salicylic Acid on Major Arterial and Venous Complications in Patients Undergoing Noncardiac Surgery
  • Embargo Lift: Monday, March 31, 2014 at 8:00am

10:30 AM

10:30 AM - 11:00AM

  • Interview: Dr. Nadia Bandstein
  • Topic: Negative High-Sensitive Troponins in the Emergency Department and Risk of Myocardial Infarction
  • Embargo lift: Sunday, March 30, 2014 at 11:45am

2:00 PM

OPEN TIME SLOT

2:30 PM

2:30 PM - 3:00 PM

  • Interviewee:Dr. Jennifer Robinson
  • Topic: The Low-density Lipoprotein Cholesterol Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy - 2 Trial: A Phase 3, Double-blind, Randomized, Placebo and Ezetimibe Controlled, Multicenter Study to Evaluate Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Combination With Statin Therapy in Subjects With Primary Hypercholesterolemia and Mixed Dyslipidemia
  • Embargo Lift: Sunday, March 30, 2014 at 8:15am

3:00 PM

3:00 PM - 3:30 PM

  • Interview: Dr. Marco Valgimigli
  • Topic: Bare Metal vs. Zotarolimus-eluting stent in Uncertain Drug-eluting Stent Candidates: A Randomized Controlled Trial
  • Embargo lift: Monday, March 31, 2014 at 11:30 AM

3:30 PM

3:30 PM - 4:00 PM

  • Interview: Dr. A. Michael Lincoff
  • Topic: Evaluation of the Dual PPAR-α/γ Agonist Aleglitazar to Reduce Cardiovascular Events in Patients with Acute Coronary Syndrome and Type 2 Diabetes Mellitus: the AleCardio Trial
  • Embargo lift: Monday, March 31, 2014 at 11:30 AM

4:00 PM

4:00 PM - 4:15 PM

  • Interviewee: Dr. Ajay Kirtane
  • Topic: Daily ACC Wrap-up in English

Sunday, March 30, 2014

9:00 AM

9:00 AM - 9:30AM *TCTMD Studio Not Available

9:30 AM

9:30 AM - 10:30AM *TCTMD Studio Not Available

10:00 AM

10:00 AM - 10:30AM *TCTMD Studio Not Available

10:30 AM

10:30 AM - 11:30AM *TCTMD Studio Not Available

11:00 AM

OPEN TIME SLOT

11:30 AM

OPEN TIME SLOT

12:00 PM

12:00 PM - 12:30 PM OPEN TIME SLOT

12:30 PM

12:30 PM - 1:00 PM

  • Interviewee: Dr. Masahiro Natsuaki
  • Topic: Two-year Outcome of a Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer: the NOBORITM Biolimus-Eluting versus XIENCETM/PROMUSTM Everolimus-eluting Stent Trial (NEXT)
  • Embargo Lift: Sunday, March 30, 2014 at 8:45am

1:00 PM

1:00 PM - 1:30 PM

  • Interview: Dr. Anders Bruun Mathiasen and Professor Jens Kastrup
  • Topic: Autotransplantation of Bone Marrow Derived Mesenchymal Stromal Cells in Patients with Severe Ischemic Heart Failure: The MSC-HF Trial
  • Embargo lift: Monday, March 31, 2014 at 11:45am

1:30 PM

1:30 PM - 2:00 PM

  • Interviewee: Dr. Rogerio Sarmentio-Leite
  • Topic: ACC Wrap-up in Portuguese

2:00 PM

2:00PM - 2:30 PM

  • Interviewee: Dr. Basil Lewis
  • Topic: ACC Wrap-up in Hebrew

2:30 PM

2:30 PM - 3:00 PM

  • Interview:Dr. Ilan Goldenberg
  • Topic: Long-term Survival with Cardiac Resynchronization Therapy in Patients with Mild Heart Failure
  • Embargo lift: Sunday, March 30, 2014 at 11:45 AM

3:00 PM

OPEN TIME SLOT

3:30 PM

3:30 PM - 4:00 PM

  • Interviewee: Dr. Roxana Mehran
  • Topic: ACC Wrap-up in English

4:00 PM

4:00 PM - 4:30 PM

  • Interviewee: Dr. Ajay Kirtane
  • Topic: ACC Wrap-up in English

4:30 PM

4:30 PM - 5:00PM *TCTMD Studio Not Available

5:00PM

5:00 PM - 5:30 PM *TCTMD Studio Not Available

5:30PM

5:30PM - 6:00 PM *TCTMD Studio Not Available

6:00PM

6:00 PM - 6:30 PM *TCTMD Studio Not Available

Monday, March 31, 2014

8:00 AM

8:00AM - 8:30AM

  • Interviewee: Dr. Deepak Bhatt
  • Topic: The Main Results of SYMPLICITY HTN-3
  • Embargo Lift: Saturday, March 29, 2014 at 9:35am

8:30 AM

8:30AM - 9:00AM

  • Interviewee: Dr. Stefan James
  • Topic: ACC Wrap-up from the Scandinavian Perspective

9:00 AM

9:00 AM - 9:30 AM

  • Interviewee: Dr. David Adams
  • Topic: A Randomized Comparison of Self-expanding Transcatheter and Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis Deemed High-Risk for Surgery
  • Embargo Lift: Saturday, March 29, 2014 at 9:10am

9:30 AM

OPEN TIME SLOT

10:00 AM

10:00 AM - 10:30 AM

  • Interviewee: Dr. Massimo Imazio
  • Topic: Efficacy And Safety Of Colchicine In Patients With Multiple Recurrences Of Pericarditis: Results Of A Multicenter, Double-blind, Placebo-controlled, Randomized Study (corp-2 Trial)
  • Embargo Lift: Sunday, March 30, 2014 at 10:45am

10:30 AM

10:30 AM - 11:00AM

  • Interviewee: Dr. Aimee Armstrong
  • Topic: One Year Follow-up of the Melody Transcatheter Pulmonary Valve Multicenter Post Approval Study
  • Embargo Lift: Sunday, March 30, 2014 at 11:15am

11:00 AM

11:00AM - 11:30AM

  • Interviewee: Dr. Phillip Raymond Schauer
  • Topic: Effect of Bariatric Surgery vs. Intensive Medical Therapy on Long-term Glycemic Control and Complications of Diabetes: 3-Year STAMPEDE Trial Results
  • Embargo Lift: Monday, March 31, 2014 at 9:00am

11:30 AM

11:30AM - 12:00PM

  • Interviewee: Dr. Ajay Kirtane
  • Topic: ACC Wrap-up in English

12:00 PM

12:00 PM - 12:30 PM

  • Interviewee: Dr. Hisao Ogawa and Dr. Tomohiro Sakamoto
  • Topic: ACC Wrap-up in Japanese

12:30 PM

12:30 PM - 1:00 PM *TCTMD Webcast - Studio Not Available

  • Interviewee: Dr. Richard Whitlock
  • Topic: Steroids in Cardiac Surgery (SIRS)
  • Embargo Lift: Monday, March 31, 2014 at 8:30am

1:00 PM

1:00 PM - 1:30 PM *TCTMD Webcast - Studio Not Available

  • Interviewee: Dr. Gennaro Sardella
  • Topic: ACC Wrap-up in Italian

1:30 PM

1:30 PM - 2:00 PM *TCTMD Webcast - Studio Not Available

  • Interviewee: Dr. Daniel Sessler
  • Topic: A Large International Trial Assessing the Effects of Clonidine on Major Arterial Events in Patients Having Noncardiac Surgery
  • Embargo Lift: Monday, March 31, 2014 at 8:15am

2:00 PM

2:00 PM – 2:30 PM *TCTMD Webcast -Studio Not Available

  • Interviewee: Dr. Juan Gaspar
  • Topic: ACC Wrap-Up in Spanish

2:30 PM

2:30 PM – 3:00 PM

  • Interviewee: Dr. Freek Verheugt
  • Topic: ACC Wrap-Up in Dutch

3:00 PM

3:00 PM - 3:30 PM

  • Interviewee: Dr. Mohamed Abdel-Wahab
  • Topic:A Randomized Comparison of Self-Expandable and Balloon-Expandable Prostheses in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement - The CHOICE Trial
  • Embargo Lift: Sunday, March 30, 2014 at 8:00am

3:30 PM

3:30 PM - 4:00 PM

  • Interviewee: Dr. Gilles Montalescot
  • Topic: ACC Wrap-up in French

4:00 PM

4:00 PM - 4:30 PM

  • Interviewee: Dr. David Holmes
  • Topic: One Year Outcomes from the STS/ACC Transcatheter Valve Therapy (TVT) Registry
  • Embargo Lift: Monday, March 31, 2014 at 10:45am

4:30 PM

4:30PM - 5:00PM

  • Interviewee: Dr. Chris Lexis
  • Topic: Metformin in Acute Myocardial Infarction
  • Embargo Lift: Monday, March 31, 2014 at 8:45am

5:00 PM

5:00 PM - 5:20 PM

  • Interviewee: Dr. Adeel Shahzad and Dr. Rod Stables (PI on Study)
  • Topic: Unfractionated Heparin versus Bivalirudin in Primary Percutaneous Coronary Intervention: A Unique Randomized Controlled Trial with Consecutive, Unselected Patient Enrollment (using Delayed Consent), Designed to Reflect Real-World, Contemporary Practice
  • Embargo Lift: Monday, March 31, 2014 at 12:30pm

5:20 PM

5:20 PM - 5:40 PM

  • Interviewee: Professor Harvey White
  • Topic: Effect of Inhibition of Lipoprotein-Associated Phospholipase A2 with Darapladib on Ischemic Events in Patients with Chronic Coronary Heart Disease: The STABILITY (STabilisation of Atherosclerotic plaque By Initiation of darapLadIb TherapY) Trial and ACC Wrap-up from the Pacific Rim Perspective
  • Embargo Lift: Sunday, March 30, 2014 at 8:00am

Tuesday, April 1, 2014

8:00 AM

OPEN TIME SLOT

8:30 AM

OPEN TIME SLOT

9:00 AM

9:00 AM - 9:30 AM *TCTMD Studio Not Available

  • Interviewee: Dr. Sigmund Silber
  • Topic: ACC Wrap Up in German

9:30 AM

OPEN TIME SLOT

10:00 AM

OPEN TIME SLOT

10:30 AM

OPEN TIME SLOT

11:00 AM

OPEN TIME SLOT

11:30 AM

OPEN TIME SLOT

Retrieved from "https://www.wikidoc.org/index.php?title=ACC_2014_schedule&oldid=960660"